Source: http://www.google.es/patents/US8052734
Timestamp: 2013-05-20 15:57:40
Document Index: 212162652

Matched Legal Cases: ['Application No. 2005251777', 'Application No. 2', 'Application No. 2', 'Application No. 09009102', 'art 1', 'art 1']

Patente US8052734 - Expandable medical device with beneficial agent delivery mechanism - Google PatentesB�squeda Im�genes Maps Play YouTube Noticias Gmail Drive M�s » B�squeda avanzada de patentes | Historial web | Iniciar sesi�n B�squeda avanzada de patentesPatentesAn expandable issue supporting device of the present invention employs ductile hinges at selected points in the expandable device. When expansion forces are applied to the device as a whole, the ductile hinges concentrate expansion stresses and strains in small well defined areas. The expandable medical...http://www.google.es/patents/US8052734?utm_source=gb-gplus-sharePatente US8052734 - Expandable medical device with beneficial agent delivery mechanism N�mero de publicaci�nUS8052734 B2Tipo de publicaci�nConcesi�n N�mero de solicitud12/138,721 Fecha de publicaci�n8 Nov 2011 Fecha de presentaci�n13 Jun 2008 Fecha de prioridad30 Mar 1998Tambi�n publicado comoEP1071490A1EP1071490B1EP2286865A1EP2289593A1EP2292181A1US6241762US6562065US7279004US7819912US8052735US20030009214US20030167085US20040122505US20050159806US20050203609US20060136038US20070067026US20080109071US20080243070US20080249609US20080294242US20120083873WO1999049928A1 InventoresJohn F. Shanley Cesionario originalInnovational Holdings, Llc Clasificaci�n de EE.UU.623/1.15 Clasificaci�n internacionalA61F2/00A61F2/06A61F2/82A61F2/84A61F2/90 Clasificaci�n cooperativaA61F2002/91541A61F2250/0068A61F2/915A61F2002/91558A61F2250/0029A61F2250/0018A61F2250/0036A61F2/91 Clasificaci�n europeaA61F 2/91A61F 2/915ReferenciasCitas de patentes (99)Otras citas (41)Enlaces externosUSPTO Cesi�n de USPTO EspacenetExpandable medical device with beneficial agent delivery mechanismUS 8052734 B2 Resumen An expandable issue supporting device of the present invention employs ductile hinges at selected points in the expandable device. When expansion forces are applied to the device as a whole, the ductile hinges concentrate expansion stresses and strains in small well defined areas. The expandable medical device including ductile hinges provides the advantages of low expansion force requirements, relatively thick walls which are radio-opaque, improved crimping properties, high crush strength, reduced elastic recoil after implantation, and control of strain to a desired level. The expandable tissue supporting device includes a plurality of elongated beams arranged in a cylindrical device and connected together by a plurality of ductile hinges. Although many ductile hinge configurations are possible, the ductile hinges preferably have a substantially constant hinge cross sectional area which is smaller than a beam cross sectional area such that as the device is expanded from a first diameter to a second diameter, the ductile hinges experience plastic deformation while the beams are not plastically deformed.
Citas de patentes Patente citada Fecha de presentaci�n Fecha de publicaci�n Solicitante T�tuloUS36577448 May 197025 Abr 1972Surgitronics CorporationMethod for fixing prosthetic implants in a living bodyUS430024419 Sep 197917 Nov 1981Carbomedics, Inc.Cardiovascular graftsUS453193612 Ene 198330 Jul 1985Gordon; Robert T.Device and method for the selective delivery of drugs to the myocardiumUS454202530 Abr 198417 Sep 1985Southern Research InstituteInjectable, long-acting microparticle formulation for the delivery of anti-inflammatory agentsUS45805681 Oct 19848 Abr 1986Cook, IncorporatedPercutaneous endovascular stent and method for insertion thereofUS46504661 Nov 198517 Mar 1987Angiobrade PartnersAngioplasty deviceUS47336657 Nov 198529 Mar 1988Expandable Grafts PartnershipExpandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graftUS47397623 Nov 198626 Abr 1988Expandable Grafts PartnershipExpandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graftUS477633726 Jun 198611 Oct 1988Expandable Grafts PartnershipExpandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graftUS480088213 Mar 198731 Ene 1989Cook IncorporatedEndovascular stent and delivery systemUS482443621 Abr 198725 Abr 1989Wolinsky; HarveyMethod for the prevention of restenosisUS48347554 Mar 198530 May 1989Pfizer Hospital Products Group, Inc.Triaxially-braided fabric prosthesisUS488911920 Ene 198826 Dic 1989Ethicon, Inc.Surgical fastener made from glycolide-rich polymer blendsUS49161931 Ago 198810 Abr 1990Allied-Signal Inc.Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lactidesUS49558788 Dic 198811 Sep 1990Biotechnology, Inc.Kit for preventing or treating arterial dysfunction resulting from angioplasty proceduresUS495750830 Oct 198718 Sep 1990Ube Industries, Ltd.Medical tubesUS49607909 Mar 19892 Oct 1990University Of KansasDerivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereofUS49694586 Jul 198713 Nov 1990Medtronic, Inc.Intracoronary stent and method of simultaneous angioplasty and stent implantUS498960122 Sep 19885 Feb 1991Medical Engineering & Development Institute, Inc.Method, apparatus, and substance for treating tissue having neoplastic cellsUS499015519 May 19895 Feb 1991Wilkoff; Howard M.Surgical stent method and apparatusUS499407122 May 198919 Feb 1991Cordis CorporationBifurcating stent apparatus and methodUS50173812 May 199021 May 1991Alza CorporationMulti-unit pulsatile delivery systemUS50190901 Sep 198828 May 1991Corvita CorporationRadially expandable endoprosthesis and the likeUS50491328 Ene 199017 Sep 1991Cordis CorporationBalloon catheter for delivering therapeutic agentsUS50530488 Nov 19901 Oct 1991Cordis CorporationThromboresistant coatingUS505916611 Dic 198922 Oct 1991Medical Innovative Technologies R & D Limited PartnershipIntra-arterial stent with the capability to inhibit intimal hyperplasiaUS505917818 Ene 199122 Oct 1991Koshin International Corporation (50% Undivided Interest)Method of percutaneously removing a thrombus from a blood vessel by using catheters and system for removing a thrombus from a blood vessel by using cathetersUS505921125 Jun 198722 Oct 1991Duke UniversityAbsorbable vascular stentUS50787269 Abr 19907 Ene 1992Kreamer; Jeffry W.Graft stent and method of repairing blood vesselsUS508562927 Sep 19894 Feb 1992Medical Engineering CorporationBiodegradable stentUS509284117 May 19903 Mar 1992Wayne State UniversityMethod for treating an arterial wall injured during angioplastyUS510241728 Mar 19887 Abr 1992Expandable Grafts PartnershipExpandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graftUS513948022 Ago 199018 Ago 1992Biotech Laboratories, Inc.Necking stentsUS515704931 Oct 199120 Oct 1992The United States Of America As Represented By The Department Of Health & Human ServicesMethod of treating cancers sensitive to treatment with water soluble derivatives of taxolUS51603418 Nov 19903 Nov 1992Advanced Surgical Intervention, Inc.Resorbable urethral stent and apparatus for its insertionUS517121728 Feb 199115 Dic 1992Indiana University FoundationMethod for delivery of smooth muscle cell inhibitorsUS51712623 Dic 199015 Dic 1992Cordis CorporationNon-woven endoprosthesisUS517661721 Oct 19915 Ene 1993Medical Innovative Technologies R & D Limited PartnershipUse of a stent with the capability to inhibit malignant growth in a vessel such as a biliary ductUS519598419 Feb 199123 Mar 1993Expandable Grafts PartnershipExpandable intraluminal graftUS519797826 Abr 199130 Mar 1993Advanced Coronary Technology, Inc.Removable heat-recoverable tissue supporting deviceUS521358025 Mar 199225 May 1993Endoluminal Therapeutics, Inc.Biodegradable polymeric endoluminal sealing processUS522309230 Abr 199129 Jun 1993James River CorporationFibrous paper cover stock with textured surface pattern and method of manufacturing the sameUS52344567 May 199210 Ago 1993Pfizer Hospital Products Group, Inc.Hydrophilic stentUS524239918 Jun 19927 Sep 1993Advanced Cardiovascular Systems, Inc.Method and system for stent deliveryUS528282319 Mar 19921 Feb 1994Medtronic, Inc.Intravascular radially expandable stentUS528325710 Jul 19921 Feb 1994The Board Of Trustees Of The Leland Stanford Junior UniversityMethod of treating hyperproliferative vascular diseaseUS528625428 Ago 199215 Feb 1994Cortrak Medical, Inc.Drug delivery apparatus and methodUS528871128 Abr 199222 Feb 1994American Home Products CorporationMethod of treating hyperproliferative vascular diseaseUS529027129 Jul 19931 Mar 1994Jernberg; Gary R.Surgical implant and method for controlled release of chemotherapeutic agentsUS529251220 Dic 19898 Mar 1994Centre Internationale De Recherches Dermatologiques (C.I.R.D.)Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least one active productUS530412122 Nov 199119 Abr 1994Boston Scientific CorporationDrug delivery system making use of a hydrogel polymer coatingUS53146889 Feb 199324 May 1994Eli Lilly And CompanyLocal delivery of dipyridamole for the treatment of proliferative diseasesUS53423484 Dic 199230 Ago 1994Kaplan; Aaron V.Method and device for treating and enlarging body lumensUS534262115 Sep 199230 Ago 1994Advanced Cardiovascular Systems, Inc.Antithrombogenic surfaceUS534442615 Abr 19936 Sep 1994Advanced Cardiovascular Systems, Inc.Method and system for stent deliveryUS538029930 Ago 199310 Ene 1995Med Institute, Inc.Thrombolytic treated intravascular medical deviceUS53838926 Nov 199224 Ene 1995Meadox FranceStent for transluminal implantationUS538392819 Ago 199324 Ene 1995Emory UniversityStent sheath for local drug deliveryUS54038583 Jul 19924 Abr 1995Rhone-Poulenc Rorer, S.A.New compositions containing taxane derivativesUS54076831 Oct 199218 Abr 1995Research Corporation Technologies, Inc.Pharmaceutical solutions and emulsions containing taxolUS541586912 Nov 199316 May 1995The Research Foundation Of State University Of New YorkTaxol formulationUS541976011 Oct 199430 May 1995Pdt Systems, Inc.Medicament dispensing stent for prevention of restenosis of a blood vesselUS543944630 Jun 19948 Ago 1995Boston Scientific CorporationStent and therapeutic delivery systemUS543968622 Feb 19938 Ago 1995Vivorx Pharmaceuticals, Inc.Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful thereforUS544151523 Abr 199315 Ago 1995Advanced Cardiovascular Systems, Inc.Ratcheting stentUS544174522 Oct 198415 Ago 1995Vestar, Inc.Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a bodyUS54434583 Dic 199322 Ago 1995Advanced Cardiovascular Systems, Inc.Multilayered biodegradable stent and method of manufactureUS544349615 Oct 199322 Ago 1995Medtronic, Inc.Intravascular radially expandable stentUS544349722 Nov 199322 Ago 1995The Johns Hopkins UniversityPercutaneous prosthetic by-pass graft and method of useUS54435008 Abr 199422 Ago 1995Advanced Cardiovascular Systems, Inc.Intravascular stentUS544772415 Nov 19935 Sep 1995Harbor Medical Devices, Inc.Medical device polymerUS544937317 Mar 199412 Sep 1995Medinol Ltd.Articulated stentUS54493822 Mar 199412 Sep 1995Boston Scientific Scimed, Inc.Minimally invasive bioactivated endoprosthesis for vessel repairUS544951311 Ago 199312 Sep 1995Research Development Corporation Of JapanPhysical trapping type polymeric micelle drug preparationUS545711315 Oct 199310 Oct 1995Eli Lilly And CompanyMethods for inhibiting vascular smooth muscle cell proliferation and restinosisUS546081712 Mar 199324 Oct 1995Allied Colloids Ltd.Particulate composition comprising a core of matrix polymer with active ingredient distributed thereinUS546286623 Sep 199331 Oct 1995Vanderbilt UniversitySemipermeable microspheres encapsulating biological materialUS546445021 Mar 19947 Nov 1995Scimed Lifesystems Inc.Biodegradable drug delivery vascular stentUS546465026 Abr 19937 Nov 1995Medtronic, Inc.Intravascular stent and methodUS54729852 Sep 19945 Dic 1995Neorx CorporationPrevention and treatment of pathologies associated with abnormally proliferative smooth muscle cellsUS547305522 Jun 19945 Dic 1995Farmitalia Carlo Erba S.R.L.Polymer-bound paclitaxel derivativesUS549636515 Jul 19945 Mar 1996Sgro; Jean-ClaudeAutoexpandable vascular endoprosthesisUS54993739 Nov 199412 Mar 1996Sony CorporationApparatus and methods for designing, analyzing or simulating signal processing functionsUS550001313 Ene 199519 Mar 1996Scimed Life Systems, Inc.Biodegradable drug delivery vascular stentUS551007715 Sep 199423 Abr 1996Medtronic, Inc.Method of making an intraluminal stentUS551205530 Sep 199430 Abr 1996Leonard BloomAnti-infective and anti-inflammatory releasing systems for medical devicesUS551678112 May 199414 May 1996American Home Products CorporationMethod of treating restenosis with rapamycinUS552309228 Ene 19944 Jun 1996Emory UniversityDevice for local drug delivery and methods for using the sameUS55273441 Ago 199418 Jun 1996Illinois Institute Of TechnologyPharmacologic atrial defibrillator and methodUS553428729 Nov 19949 Jul 1996Schneider (Europe) A.G.Methods for applying an elastic coating layer on stentsUS554520821 Dic 199313 Ago 1996Medtronic, Inc.Intralumenal drug eluting prosthesisUS554521022 Sep 199413 Ago 1996Advanced Coronary Technology, Inc.Method of implanting a permanent shape memory alloy stentUS554556925 May 199513 Ago 1996Neorx CorporationPrevention and treatment of pathologies associated with abnormally proliferative smooth muscle cellsUS555195412 Oct 19943 Sep 1996Scimed Life Systems, Inc.Biodegradable drug delivery vascular stentUS555418227 Abr 199510 Sep 1996Medtronic, Inc.Method for preventing restenosisUS555641311 Mar 199417 Sep 1996Advanced Cardiovascular Systems, Inc.Coiled stent with locking endsUS55629227 Feb 19958 Oct 1996Cedars-Sinai Medical CenterDrug incorporating and release polymeric coating for bioprosthesisUS556314626 May 19958 Oct 1996American Home Products CorporationMethod of treating hyperproliferative vascular diseaseUS557108916 Dic 19945 Nov 1996Cardiovascular Dynamics, Inc.Low profile perfusion catheterOtras citasReferencia1Australian Office Action dated May 3, 2010 corresponding to Application No. 2005251777.2Berk, Bradford C. MD et al., Pharmacologic Roles of Heparin and Glucocorticoids to Prevent Restenosis After Coronary Angioplasty, JACC, vol. 17, No. 6, May 1991: 111B-7B.3Campbell, Gordon R. et al., Phenotypic Modulation of Smooth Muscle Cells in Primary Culture, Vascular Smooth Muscle Cells in Culture, CRC Press 1987, pp. 39-55.4Canadian Search Report dated Mar. 19, 2009 corresponding to Application No. 2,424,305.5Canadian Search Report dated May 27, 2008 corresponding to Application No. 2,424,305.6Clowes, Alexander W. et al., Kinetics of Cellular Proliferation after Arterial Injury, Circulation Research, vol. 58, No. 6, Jun. 1986, pp. 839-845.7Clowes, Alexander W. et al., Significance of Quiescent Smooth Muscle Migration in the Injured Rat Carotid Artery, Cir Res 56: pp. 139-145, 1985.8Clowes, Alexander W. et al., Suppression by Heparin of smooth muscle cell proliferation in injured arteries, Nature, vol. 265, Feb. 17, 1977, pp. 625-626.9Coburn, Michael D., MD et al., Dose Responsive Suppression of Myointimal Hyperlasia by Dexamethasone, Journal of Vascular Surgery, vol. 15, No. 3, Mar. 1992, pp. 510-518.10Emanuelsson, H. et al., The JOSTENT Coronary Stent Range, JOMED International AB, Helsingborg, Sweden, Chapter 16, p. 123-140.11European Office Action dated Jun. 11, 2010 in Application No. 09009102.6.12Fischman, David L., MD et al., A Randomized Comparison of coronary-Stent Implantation with Balloon Angioplasty in Treatment of Coronary Artery Disease, The New England Journal of Medicine, vol. 331, No. 8, Aug. 25, 1994, 496-501.13Franklin, Stephen, M. MD et al., Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials, Coronary Artery Disease, Mar. 1993, vol. 4, No. 3, 232-242.14Grayson, A.C. Richards et al., "Multi-pulse Drug Delivery From a Resorbable Polymeric Microchip Device", Nature Materials, vol. 2, Nov. 2003, pp. 767-770.15Gregory, Clare R. et al., Rapamycin Inhibits Arterial Intimal Thickening Caused by Both Alloimmune and Mechanical Injury, Transplantation vol. 55, No. 6, Jun. 1993, pp. 1409-1418.16Guyton , John, R. et al., Inhibition of Rat Arterial Smooth Muscle Cell Proliferation by Heparin, Circulation Research, vol. 46, No. 5, May 1980, pp. 625-634.17Hakan, E. et al., The Jostent Coronary Stent Range, Ch. 19.18Halsey, W. (ed.): Dictionary A-K, New ork: Macmillan Educational Co., 1986, p. 491.19Hasson, Goran K., MD., et al., Interferon-Inhibits Arterial Stenosis After Injury, Circulation, vol. 84, No. 3, Sep. 1991, pp. 1266-1272.20Hasson, Goran K., MD., et al., Interferon�Inhibits Arterial Stenosis After Injury, Circulation, vol. 84, No. 3, Sep. 1991, pp. 1266-1272.21Hiatt, B.L. et al., "The Drug-Eluting Stent: Is it the Holy Grail?" Reviews in Cardiovascular medicine, 2001, vol. 2, No. 4, pp. 190-196.22Hwang, C.W. et al., Physiological Transport Forces Govern Drug Distribution for Stent-based Delivery, Circulation, 104, 2001, pp. 600-605.23Jonasson, Lena et al, Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury, Proc. Natl. Acad. Sci USA 85 (1988), pp. 2303-2306.24Kornowski, R. et al., "Slow-Release Taxol coated GR11 Stents Reduce Neointima Formation in a Porcine Coronary in Stent Restenosis Model" Abstract from the American Hear Associatiion's 70th Scientific Sessions, Nov. 9-12, 1997.25Lange, Richard A. MD et al., Restenosis After Coronary Balloon Angioplasty, Annu. Rev. Med. 1991, 42:127-32.26Liu, Ming Wei, MD et al., Restenosis After Coronary Angioplasty Potential Biologic Determinants and Role of Intimal Hyperplasia, Circulation 1989, 79:1374-1387.27Liu, Ming, W. MD et al., Trapidil in Preventing Restenosis After Balloon Angioplasty in the Atherosclerotic Rabbit, Circulation, vol. 81, No. 3, Mar. 1990, pp. 1089-1093.28Lundergan, Conor F., MD et al., Peptide Inhibition of Myointimal Proliferation by Angiopeptin, a Somatostation Analogue, JACC, vol. 17, No. 6, May 1991: 132B-6B.29Majesky, Mark W., et al., Heparin Regulates Smooth Muscle S Phase Entry in the Injured Rat Carotid Artery, Circulation Research, vol. 61, No. 2, Aug. 1987, pp. 296-300.30Marx, Steven O. et al., Rapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells, Circulation Research, 1995; 76(3):412-417.31Nemecek, Georgina M. et al., Terbinafine Inhibits the Mitogenic Response to Platelet-Derived Growth Factor in Vitro and Neointimal Proliferation in Vivo, The Journal of Pharmacology and Experimental Therapeutics, vol. 248, No. 3, 1998, 1167-1174.32Okada, Tomohisa, MD et al., Localized Release of Perivascular Heparin Inhibits Intimal Proliferaiton after Endothelial Injury without Systemic Anticoagulation, Neurosurgery, vol. 25, No. 6,1989, 892-898.33Poon, Michael et al., Rapamycin Inhibits Vascular Smooth Muscle Cell Migration, J. Clin. Invest., vol. 98, No. 10, Nov. 1996, 2277-2283.34Popma, Jeffrey J. MD et al., Clinical Trials of Restenosis After Coronary Angioplasty, Circulation vol. 84, No. 3, Sep. 1991, pp. 1426-1436.35Powell, Jerry S. et al., Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury, Science, vol. 245, Jul. 14, 1989, pp. 186-188.36Serruys, P. W. et al., Evaluation of Ketanserin in the Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty-A Multicenter Randomized Double-Blind Placebo-Controlled Trial, Circulation, vol. 88, No. 4, Part 1, Oct. 1993, pp. 1588-1601.37Serruys, P. W. et al., Evaluation of Ketanserin in the Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty�A Multicenter Randomized Double-Blind Placebo-Controlled Trial, Circulation, vol. 88, No. 4, Part 1, Oct. 1993, pp. 1588-1601.38Serruys, Patrick W. et al., Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries, Circulation, 1996, 93:412-422.39Siekierka, John J., Probing T-Cell Signal Transduction Pathways with the Immunosuppressive Drugs, FK-506 and Rapamycin, Immunologic Research 1994,13:110-116.40Snow, Alan D. et al., Heparin Modulates the Composition of th Extracellular Matrix Domain Surrounding Arterial Smooth Muscle Cells, American Journal of Pathology, vol. 137, No. 2, Aug. 1990, pp. 313-330.41Vasey, Charles G. et al., Clinical Cardiology: Stress Echo and Coronary Flow, Supplement II Circulation, vol. 80, No. 4, Oct. 1989, II-66.GirarImagen originalP�gina principal de Google - Sitemap - Descargas masivas de USPTO - Pol�tica de privacidad - Condiciones de servicio - Acerca de Google Patentes - Danos tu opini�nDatos proporcionados por IFI CLAIMS Patent Services©2012 Google